Skip to main content

Altertox

Translating Life Sciences research for a lasting impact

Altertox is a Science to Policy company specializing in life sciences. It brings together a team of communication experts with a strong scientific background.
 
Strategically located at the heart of the EU institutions in Brussels, Altertox has earned the trust of stakeholders, such as non-governmental organizations, trade associations, policymakers at the European Commission and the European Parliament. 
 
Altertox’s current portfolio in life sciences research and policy focuses on cutting-edge areas such as AI in healthcare, One Health and product safety (NAMs).
 
As a key player in multiple EU Horizon projects, Altertox serves as a work package leader for communication and dissemination, driving impactful engagement and collaboration. 
01

Life Sciences to Policy

A Direct Line Between Research and EU Institutions

02

EU Horizon Projects

Did you know that EU tender average application success rate is ca. 12% ? Altertox’s current application success rate is 57% since 2017.

03

Life Sciences Communication

Did you know that an average opening newsletter rate is 20%? Altertox’s newsletter opening rate is in average 50% !

04

Toxicology

Did you know that in 2022, the European Parliament adopted a motion of resolution to phase out animal testing? Consequently, the European Commission launched a roadmap to phase out animal testing in Europe.

Stay ahead of life sciences policy.

Subscribe to our Newsletter:
Stay Updated on Policy News and Company Developments!

They trusted our experience